ANTI-SCHIZOPHRENIC DRUGS - MEMBRANE RECEPTOR-SITES OF ACTION

被引：229
作者：
SEEMAN, P [1 ]
机构：
[1] UNIV TORONTO,DEPT PHARMACOL,TORONTO M5S 1A8,ONTARIO,CANADA
来源：
BIOCHEMICAL PHARMACOLOGY | 1977年 / 26卷 / 19期
关键词：
D O I：
10.1016/0006-2952(77)90340-9
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1741 / 1748
页数：8
相关论文
共 102 条
[21]  
DELAY J, 1952, Ann Med Psychol (Paris), V110, P267
[22]   STEREOSPECIFICITY OF INTERACTION OF NEUROLEPTIC DRUGS WITH NEUROTRANSMITTERS AND CORRELATION WITH CLINICAL POTENCY [J].
ENNA, SJ ;
BENNETT, JP ;
BURT, DR ;
CREESE, I ;
SNYDER, SH .
NATURE, 1976, 263 (5575) :338-341
[23]   GAS-CHROMATOGRAPHIC METHOD FOR DETERMINING HALOPERIDOL - SENSITIVE PROCEDURE FOR STUDYING SERUM CONCENTRATION AND PHARMACOKINETICS OF HALOPERIDOL IN PATIENTS [J].
FORSMAN, A ;
MARTENSSON, E ;
NYBERG, G ;
OHMAN, R .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 286 (02) :113-124
[24]   RELATIONSHIP BETWEEN LIPOPHILIC NATURE OF TRICYCLIC NEUROLEPTICS AND ANTIDEPRESSANTS, AND HISTAMINE-RELEASE [J].
FRISKHOL.M ;
VANDERKL.E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1972, 18 (02) :139-&
[25]   EFFECT OF L-DOPA ON YOUNG PATIENTS WITH SIMPLE SCHIZOPHRENIA, TREATED WITH NEUROLEPTIC DRUGS - DOUBLE-BLIND CROSSOVER TRIAL WITH MADOPAR AND PLACEBO [J].
GERLACH, J ;
LUHDORF, K .
PSYCHOPHARMACOLOGIA, 1975, 44 (01) :105-110
[26]  
GRUENER R, 1972, J PHARMACOL-PARIS, V181, P161
[27]  
HALARIS AE, 1975, BIOLOGY MAJOR PSYCHO, V54, P247
[28]  
HAMBERGER B, 1973, EUR J CLIN PHARMACOL, V5, P1
[29]  
HEIKKILA RE, 1976, RES COMMUN CHEM PATH, V13, P237
[30]   COMMON MODE OF ACTION OF 3 AGENTS THAT DECREASE TRANSIENT CHANGE IN SODIUM PERMEABILITY IN NERVES [J].
HILLE, B .
NATURE, 1966, 210 (5042) :1220-&
12345678910